S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
BREAKING: The truth about war with China (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
BREAKING: The truth about war with China (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
BREAKING: The truth about war with China (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
With oil prices slumping, OPEC+ producers weigh more production cuts
BREAKING: The truth about war with China (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
LON:EKF

EKF Diagnostics (EKF) Share Forecast, Price & News

GBX 27.60
-0.70 (-2.47%)
(As of 06/2/2023 ET)
Compare
Today's Range
27.32
28.90
50-Day Range
24.70
31.30
52-Week Range
23.10
52.94
Volume
585,636 shs
Average Volume
1.01 million shs
Market Capitalization
£125.23 million
P/E Ratio
N/A
Dividend Yield
3.62%
Price Target
N/A

EKF stock logo

About EKF Diagnostics (LON:EKF) Stock

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls. Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-party businesses and laboratory services. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

Receive EKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

EKF Stock News Headlines

The Global Point of Care Diagnostics Market
How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
Globally Pregnancy Test Market Growth Rate 2023
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
EKF Diagnostics Holdings plc (EKF.L)
Rapid Medical Diagnostic Kits Market Share by 2031
Hematology Testing Equipment Market Demand by 2031
See More Headlines

EKF Price History

Industry, Sector and Symbol

Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
356
Year Founded
N/A

Profitability

Net Income
£-10,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£66.64 million
Cash Flow
GBX 2.59 per share
Book Value
GBX 16 per share

Miscellaneous

Free Float
N/A
Market Cap
£125.23 million
Optionable
Not Optionable
Beta
0.74

Key Executives

  • Mr. David Michael Salter (Age 62)
    CEO & Exec. Director
    Comp: $262k
  • Mr. Marc Peter Davies (Age 43)
    CFO & Director
  • Mr. Andrew Webb
    Chief Exec. Officer of Ekf Molecular













EKF Stock - Frequently Asked Questions

How have EKF shares performed in 2023?

EKF Diagnostics' stock was trading at GBX 50 at the start of the year. Since then, EKF stock has decreased by 44.8% and is now trading at GBX 27.60.
View the best growth stocks for 2023 here
.

How often does EKF Diagnostics pay dividends? What is the dividend yield for EKF Diagnostics?

EKF Diagnostics declared a dividend on Tuesday, March 28th. Stockholders of record on Thursday, November 2nd will be given a dividend of GBX 1.20 per share on Friday, December 1st. This represents a yield of 4.59%. The ex-dividend date is Thursday, November 2nd. The official announcement can be accessed at this link.
Read our dividend analysis for EKF
.

Is EKF Diagnostics a good dividend stock?

EKF Diagnostics (LON:EKF) pays an annual dividend of GBX 1 per share and currently has a dividend yield of 4.24%. EKF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for EKF.

What other stocks do shareholders of EKF Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKF Diagnostics investors own include ERBA Diagnostics (ERBA), Kirkland Lake Gold (KLG), Telford Homes (TEF), ASOS (ASC), Advanced Computer Software Group (asw), boohoo group (BOO), Newmont (NEM), SolGold (SOLG), Arcontech Group (ARC) and Alliance Pharma (APH).

What is EKF Diagnostics' stock symbol?

EKF Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "EKF."

How do I buy shares of EKF Diagnostics?

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is EKF Diagnostics' stock price today?

One share of EKF stock can currently be purchased for approximately GBX 27.60.

How much money does EKF Diagnostics make?

EKF Diagnostics (LON:EKF) has a market capitalization of £125.23 million and generates £66.64 million in revenue each year. The company earns £-10,100,000.00 in net income (profit) each year or GBX (0.02) on an earnings per share basis.

How many employees does EKF Diagnostics have?

The company employs 356 workers across the globe.

How can I contact EKF Diagnostics?

EKF Diagnostics' mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The official website for the company is www.ekfdiagnostics.com. The company can be reached via phone at +44-29-20710570.

This page (LON:EKF) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -